Zeke Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.27M | Sell |
31,313
-3,414
| -10% | -$139K | 0.08% | 115 |
|
|
2022
Q3 | $2.27M | Hold |
34,727
| – | – | 0.17% | 64 |
|
|
2022
Q2 | $2.11M | Buy |
34,727
+4,614
| +15% | +$280K | 0.14% | 72 |
|
|
2022
Q1 | $1.89M | Buy |
30,113
+6,180
| +26% | +$388K | 0.1% | 97 |
|
|
2021
Q4 | $1.81M | Buy |
23,933
+10,804
| +82% | +$819K | 0.11% | 63 |
|
|
2021
Q3 | $1.47M | Sell |
13,129
-526
| -4% | -$58.9K | 0.08% | 77 |
|
|
2021
Q2 | $2.21M | Buy |
+13,655
| New | +$2.21M | 0.14% | 63 |
|